The next leap in biotech moves beyond applying AI to existing data. CZI pioneers a model where 'frontier biology' and 'frontier AI' are developed in tandem. Experiments are now designed specifically to generate novel data that will ground and improve future AI models, creating a virtuous feedback loop.

A "software-only singularity," where AI recursively improves itself, is unlikely. Progress is fundamentally tied to large-scale, costly physical experiments (i.e., compute). The massive spending on experimental compute over pure researcher salaries indicates that physical experimentation, not just algorithms, remains the primary driver of breakthroughs.

Scientific research is being transformed from a physical to a digital process. Like musicians using GarageBand, scientists will soon use cloud platforms to command remote robotic labs to run experiments. This decouples the scientist from the physical bench, turning a capital expense into a recurring operational expense.

CZI's Biohub model hinges on a simple principle: physically seating biologists and engineers from different institutions (Stanford, UCSF, Berkeley) together. This direct proximity fosters collaboration and creates hybrid experts, overcoming the institutional silos often reinforced by traditional grant-based funding.

CZI focuses on creating new tools for science, a 10-15 year process that's often underfunded. Instead of just giving grants, they build and operate their own institutes, physically co-locating scientists and engineers to accelerate breakthroughs in areas traditional funding misses.

CZI's virtual cell models act as a computational "model organism," enabling scientists to run high-risk experiments in silico. This approach dramatically lowers the cost and time required to test novel ideas, encouraging more ambitious research that might otherwise be prohibitive.

Instead of funding small, incremental research grants, CZI's philanthropic strategy focuses on developing expensive, long-term tools like AI models and imaging platforms. This provides leverage to the entire scientific community, accelerating the pace of the whole field.

Fundraising is easier when pitching a predictable plan like 'buy X GPUs to get Y performance.' It's much harder to raise for uncertain, long-term research, even if that's where the next true breakthrough lies. This creates a market bias towards capital expenditure over pure R&D.

The infrastructure demands of AI have caused an exponential increase in data center scale. Two years ago, a 1-megawatt facility was considered a good size. Today, a large AI data center is a 1-gigawatt facility—a 1000-fold increase. This rapid escalation underscores the immense and expensive capital investment required to power AI.